Evidence map›Paper›PMID 25872977›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2015

Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye.

K J Paunicka, J Mellon, D Robertson, M Petroll, J R Brown, J Y Niederkorn

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Immune regulation of the ocular surface.Experimental eye research · 2022
    Review
  16. Immunity and pain in the eye: focus on the ocular surface.Clinical and experimental immunology · 2022
    Review
  17. Review
  18. Review
  19. "Corneal Nerves, CD11cFrontiers in immunology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K J PaunickaDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
J MellonDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
D RobertsonDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
M PetrollDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
J R BrownDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
J Y NiederkornDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
The University of Texas Southwestern Medical Center · US

Funding

THE IMMUNOBIOLOGY OF CORNEAL ALLOGRAFTSR01EY007641 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI NIEDERKORN, JERRY · 1988 to 2016
$5.6M
Core Grant for Vision ResearchP30EY020799 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI NIEDERKORN, JERRY · 2010 to 2016
$4.1M
NEI NIH HHS EY007641NEI NIH HHS EY020799NEI NIH HHS P30 EY020799NEI NIH HHS R01 EY007641
6 · The paper itself

Abstract

Less than 10% of corneal allografts undergo rejection even though HLA matching is not performed. However, second corneal transplants experience a threefold increase in rejection, which is not due to prior sensitization to histocompatibility antigens shared by the first and second transplants since corneal grafts are selected at random without histocompatibility matching. Using a mouse model of penetrating keratoplasty, we found that 50% of the initial corneal transplants survived, yet 100% of the subsequent corneal allografts (unrelated to the first graft) placed in the opposite eye underwent rejection. The severing of corneal nerves that occurs during surgery induced substance P (SP) secretion in both eyes, which disabled T regulatory cells that are required for allograft survival. Administration of an SP antagonist restored immune privilege and promoted graft survival. Thus, corneal surgery produces a sympathetic response that permanently abolishes immune privilege of subsequent corneal allografts, even those placed in the opposite eye and expressing a completely different array of foreign histocompatibility antigens from the first corneal graft.

Indexed as

Corneal TransplantationSensory Receptor CellsAllograftsAnimalsCorneaDenervationFemaleGraft RejectionGraft SurvivalHistocompatibility AntigensImmune ToleranceMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred C57BLModels, AnimalHistocompatibility AntigensSubstance PBasic (laboratory) research/sciencecorneal transplantation/ophthalmologyimmune regulationrejectiontolerance: experimental

Identifiers

PMID25872977
PMCPMC4590984
OpenAlexW1950309699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.